Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.2
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of option activity
          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Yrs)     Value  
Outstanding, January 1, 2022     2,415,000     $ 3.73              
Granted    
-
     
-
                 
Exercised    
-
     
-
                 
Expired    
-
     
-
                 
Forfeited    
-
     
-
                 
Outstanding, March 31, 2022     2,415,000     $ 3.73       7.27     $
           -
 
Exercisable, March 31, 2022     1,600,000     $ 3.80       6.57     $
-
 

 

Schedule of options outstanding and exercisable
Options Outstanding     Options Exercisable  
            Weighted        
      Outstanding     Average     Exercisable  
Exercise     Number of     Remaining Life     Number of  
Price     Options     In Years     Options  
$ 2.11       80,000       8.25       20,000  
$ 2.17       120,000       8.35       120,000  
$ 2.21       350,000       9.29       200,000  
$ 2.48       160,000       9.10       40,000  
$ 4.09       1,425,000       5.60       1,060,000  
$ 5.66       280,000       7.47       160,000  
          2,415,000       6.57       1,600,000  

 

Schedule of non-vested restricted common stock activity
          Weighted  
    Number of     Average  
    Restricted     Grant Date  
    Stock     Fair Value  
Non-vested balance, January 1, 2022     80,000     $ 2.00  
Vested     (80,000 )     2.00  
Non-vested balance, March 31, 2022    
-
    $
-